SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...

Anti-aging concern Unity Biotechnology, Inc. (UBX) saw its share price collapse after its lead candidate (UBX0101) flunked a Phase 2 study in August 2020. The setback forced a restructuring with a ...

Technical indicators imply U's continued strong performance. The stock is trading above its 50-day moving average, signaling robust upward momentum and price stability. This technical strength ...

We are actively working to enhance your experience by translating more content. However, please be aware that the page you are about to visit has not yet been translated. We appreciate your ...